These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 21724929)
1. Vancomycin: a 50-something-year-old antibiotic we still don't understand. Schilling A; Neuner E; Rehm SJ Cleve Clin J Med; 2011 Jul; 78(7):465-71. PubMed ID: 21724929 [TBL] [Abstract][Full Text] [Related]
2. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Deresinski S Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789 [TBL] [Abstract][Full Text] [Related]
3. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment]. Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080 [No Abstract] [Full Text] [Related]
4. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant]. Lepe JA; Gil-Navarro MV; Santos-Rubio MD; Bautista J; Aznar J Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient. Norazah A; Salbiah N; Nurizzat M; Santhana R Med J Malaysia; 2009 Jun; 64(2):166-7. PubMed ID: 20058580 [TBL] [Abstract][Full Text] [Related]
8. The role of vancomycin in the treatment paradigm. Stevens DL Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121 [TBL] [Abstract][Full Text] [Related]
9. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus. Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996 [TBL] [Abstract][Full Text] [Related]
10. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462 [TBL] [Abstract][Full Text] [Related]
11. Vancomycin dosing and monitoring 2 years after the guidelines. Lomaestro BM Expert Rev Anti Infect Ther; 2011 Jun; 9(6):657-67. PubMed ID: 21692671 [TBL] [Abstract][Full Text] [Related]
12. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers? Veer P; Chande C; Chavan S; Wabale V; Chopdekar K; Bade J; Joshi A Indian J Med Microbiol; 2010; 28(4):413-4. PubMed ID: 20966589 [No Abstract] [Full Text] [Related]
13. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC? Patel K; Crumby AS; Maples HD Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329 [TBL] [Abstract][Full Text] [Related]
19. Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections? Yamaki J; Lee M; Shriner KA; Wong-Beringer A Diagn Microbiol Infect Dis; 2011 May; 70(1):124-30. PubMed ID: 21392923 [TBL] [Abstract][Full Text] [Related]
20. New target concentrations for vancomycin in Hong Kong. You JH; Chow SS; Lui JW; Ip M Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378 [No Abstract] [Full Text] [Related] [Next] [New Search]